Cargando…

Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension

AIMS: While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Ravi B., Li, Emily, Benefield, Brandon C., Swat, Stanley A., Polsinelli, Vincenzo B., Carr, James C., Shah, Sanjiv J., Markl, Michael, Collins, Jeremy D., Freed, Benjamin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083501/
https://www.ncbi.nlm.nih.gov/pubmed/31903694
http://dx.doi.org/10.1002/ehf2.12565
_version_ 1783508548599152640
author Patel, Ravi B.
Li, Emily
Benefield, Brandon C.
Swat, Stanley A.
Polsinelli, Vincenzo B.
Carr, James C.
Shah, Sanjiv J.
Markl, Michael
Collins, Jeremy D.
Freed, Benjamin H.
author_facet Patel, Ravi B.
Li, Emily
Benefield, Brandon C.
Swat, Stanley A.
Polsinelli, Vincenzo B.
Carr, James C.
Shah, Sanjiv J.
Markl, Michael
Collins, Jeremy D.
Freed, Benjamin H.
author_sort Patel, Ravi B.
collection PubMed
description AIMS: While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV). METHODS AND RESULTS: We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm(2) in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). CONCLUSIONS: Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload.
format Online
Article
Text
id pubmed-7083501
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70835012020-03-24 Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension Patel, Ravi B. Li, Emily Benefield, Brandon C. Swat, Stanley A. Polsinelli, Vincenzo B. Carr, James C. Shah, Sanjiv J. Markl, Michael Collins, Jeremy D. Freed, Benjamin H. ESC Heart Fail Original Research Articles AIMS: While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV). METHODS AND RESULTS: We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm(2) in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). CONCLUSIONS: Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. John Wiley and Sons Inc. 2020-01-05 /pmc/articles/PMC7083501/ /pubmed/31903694 http://dx.doi.org/10.1002/ehf2.12565 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Patel, Ravi B.
Li, Emily
Benefield, Brandon C.
Swat, Stanley A.
Polsinelli, Vincenzo B.
Carr, James C.
Shah, Sanjiv J.
Markl, Michael
Collins, Jeremy D.
Freed, Benjamin H.
Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title_full Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title_fullStr Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title_full_unstemmed Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title_short Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
title_sort diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083501/
https://www.ncbi.nlm.nih.gov/pubmed/31903694
http://dx.doi.org/10.1002/ehf2.12565
work_keys_str_mv AT patelravib diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT liemily diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT benefieldbrandonc diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT swatstanleya diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT polsinellivincenzob diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT carrjamesc diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT shahsanjivj diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT marklmichael diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT collinsjeremyd diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension
AT freedbenjaminh diffuserightventricularfibrosisinheartfailurewithpreservedejectionfractionandpulmonaryhypertension